The oncogenic role of the In1-ghrelin splicing variant in prostate cancer aggressiveness.
Hormaechea-Agulla D, Gahete MD, Jiménez-Vacas JM, Gómez-Gómez E, Ibáñez-Costa A, L-López F, Rivero-Cortés E, Sarmento-Cabral A, Valero-Rosa J, Carrasco-Valiente J, Sánchez-Sánchez R, Ortega-Salas R, Moreno MM, Tsomaia N, Swanson SM, Culler MD, Requena MJ, Castaño JP, Luque RM.
Hormaechea-Agulla D, et al.
Mol Cancer. 2017 Aug 29;16(1):146. doi: 10.1186/s12943-017-0713-9.
Mol Cancer. 2017.
PMID: 28851363
Free PMC article.